Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (DRKS00037946) titled 'PFBC-Registry "Fahr-NET": Registry study for clinical and genetic characterization, biomarker development, and establishment of a cohort for future clinical therapy development' on Sept. 29.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: other
Primary Sponsor: Klinik fur Neurologie der Universitatsklinik Ulm (RKU Ulm)
Condition:
PFBC (synonyms Fahr disease, PBGC, symmetric basal ganglia calcification, etc.)
ORPHA:1980
Intervention:
Group 1: Patients diagnosed with PFBC (synonym Fahr's disease, PBGC, symmetric basal ganglia calcification, etc.) undergo a ...